Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Learn how to choose a low-fee Dividend Aristocrats ETF and what fees to watch. This intro covers cost factors and quick tips for a cost-efficient selection.
24,603 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Axcelis Technologies has seen its stock surge this year, riding AI-chip demand. This guide breaks down what the compa...
As SuRo Capital releases its Q4 2025 results, investors need a clear playbook. This deep dive breaks down the key met...
When micron stock just dropped, it sparked questions about the memory market and Micron's long-term roadmap. This gui...
June's trading floor is flashing mixed signals: a SpaceX-inspired rally taps telecom names, but EchoStar pulls back o...
AeroVironment recently reported earnings that caught the market off guard in a good way. This article breaks down wha...
Oil prices sprint higher, then pull back, leaving investors on edge. This piece explains how those moves could push i...
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Micron is set to report earnings in June, and investors are laser-focused on a single number that could redefine MU’s...
Biogen’s $1 billion move on a mystery company has investors buzzing. This article breaks down why the deal could be a...
Investing in builders requires more than chasing growth. This deep dive unpacks why dream finders homes: promising st...
Investors chasing high-tech breakthroughs often bet on early-stage companies like Rigetti. This article breaks down w...